M. Ingham
Impact in
- Family Practice top 5%
- Medication Adherence and Compliance
- Psychiatry and Mental health top 10%
- Schizophrenia research and treatment
- Attention Deficit Hyperactivity Disorder
Papers in
-
- Medication Adherence and Compliance 5
-
- Schizophrenia research and treatment 4
- Attention Deficit Hyperactivity Disorder 3
- Co-authors
- Keith Karcher (1 shared paper)Nicholas A Keks (1 shared paper)Trevor van Mierlo (1 shared paper)Penny S. Albright (1 shared paper)Jacques LeLorier (1 shared paper)David L. Keegan (1 shared paper)Susan C. Bolge (2 shared papers)Lieven Annemans (3 shared papers)
- Journals
- Value in Health (6 papers)Journal of Medical Economics (2 papers)Clinical Therapeutics (2 papers)Medical Decision Making (1 paper)Lara D. Veeken (1 paper)
- Partner nations
- United StatesUnited KingdomBelgium
In The Last Decade
M. Ingham
22 papers receiving 309 citations
Peers
Comparison fields: 5 of 45
- Family Practice 40
- Psychiatry and Mental health 139
- Critical Care and Intensive Care Medicine 11
- Rheumatology 31
- Molecular Medicine 13
Countries citing papers authored by M. Ingham
This map shows the geographic impact of M. Ingham's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by M. Ingham with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites M. Ingham more than expected).
Fields of papers citing papers by M. Ingham
This network shows the impact of papers produced by M. Ingham. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by M. Ingham. The network helps show where M. Ingham may publish in the future.
Co-authors
The 25 scholars most cited alongside M. Ingham, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 24 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 75 | |
| 2 | 1996 | 58 | |
| 3 | 2015 | 40 | |
| 4 | 2008 | 33 | |
| 5 | 2017 | 30 | |
| 6 | 2017 | 20 | |
| 7 | 2017 | 13 | |
| 8 | 2019 | 12 | |
| 9 | 2010 | 8 | |
| 10 | 2012 | 7 | |
| 11 | 2019 | 7 | |
| 12 | 2003 | 6 | |
| 13 | 2002 | 5 | |
| 14 | 2021 | 5 | |
| 15 | Estimating cost-effectiveness of concerta oros in attention-deficit/hyperactivity disorder (ADHD) - Adapting the Canadian coordinating office for health technology assessment's (CCOHTA) economic model of methylphenidate immediate release versus behavioural interventions from a parent's perspective. Poster presentation at the ISPOR 5th annual European Conference. Rotterdam 3-5/11/2002. | 2002 | 4 |
| 16 | Novel Adherence Measures for Infusible Therapeutic Agents Indicated for Rheumatoid Arthritis. | 2015 | 4 |
| 17 | 2014 | 2 | |
| 18 | 2016 | 2 | |
| 19 | 2023 | 2 | |
| 20 | 2001 | 1 |
About M. Ingham
M. Ingham is a scholar working on Family Practice, Psychiatry and Mental health, Economics and Econometrics, Critical Care and Intensive Care Medicine and Genetics, having authored 24 papers that have together received 337 indexed citations. Recurring topics across this work include Medication Adherence and Compliance (5 papers), Schizophrenia research and treatment (4 papers), Health Systems, Economic Evaluations, Quality of Life (4 papers), Inflammatory Bowel Disease (4 papers), Attention Deficit Hyperactivity Disorder (3 papers), Pharmaceutical Economics and Policy (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers) and Nosocomial Infections in ICU (2 papers). The work is most often cited by research in Family Practice (40 citations), Psychiatry and Mental health (139 citations), Critical Care and Intensive Care Medicine (11 citations), Rheumatology (31 citations) and Molecular Medicine (13 citations). M. Ingham has collaborated with scholars based in United States, United Kingdom and Belgium. Frequent co-authors include Keith Karcher, Nicholas A Keks, Trevor van Mierlo, Penny S. Albright, Jacques LeLorier, David L. Keegan, Susan C. Bolge, Lieven Annemans, Dilip Nathwani and Sanjay Merchant. Their work appears in journals such as Value in Health, Journal of Medical Economics, Clinical Therapeutics, Medical Decision Making and Lara D. Veeken.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.